Rohra Chemicals & Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 21-05-2024
- Paid Up Capital ₹ 0.10 M
as on 21-05-2024
- Company Age 4 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit 49.85%
(FY 2022)
- Ebitda 49.85%
(FY 2022)
- Net Worth -50.32%
(FY 2022)
- Total Assets 99.81%
(FY 2022)
About Rohra Chemicals & Pharmaceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Prashant Rohra and Prakash Rohra serve as directors at the Company.
- CIN/LLPIN
U24239GJ2020PTC113521
- Company No.
113521
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 May 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rohra Chemicals & Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prakash Rohra  | Managing Director | 02-May-2020 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prashant Rohra | Director | 02-May-2020 | Current |
Financial Performance of Rohra Chemicals & Pharmaceuticals.
Rohra Chemicals & Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 49.85% increase in profit. The company's net worth observed a substantial decline by a decrease of 50.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rohra Chemicals & Pharmaceuticals?
Unlock access to Rohra Chemicals & Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Cosmos Textile Mills Pvt LtdActive 48 years 10 monthsPrashant Rohra and Prakash Rohra are mutual person
- Htkp Industries Private LimitedActive 4 years 28 days
Prashant Rohra and Prakash Rohra are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rohra Chemicals & Pharmaceuticals?
Rohra Chemicals & Pharmaceuticals has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rohra Chemicals & Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rohra Chemicals & Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
